cosentyx crushed through 54 wk. at 102 wk all was equal. Also faster onset with cosentyx. It’s already out there. Google it.
You are chasing shadows. It’s called Risankizimab. You will be hearing a lot about it. Tremfa’s time of death is April 2019. Pasi scores? Try 90/90 at week 16. Game over.
At Week 16 PASI 90 was achieved by 75.3% patients receiving risankizumab versus 4.9% receiving placebo vs. 42% receiving ustekinumab
Drop the mike and walk away. Abbvie cuts the head off JnJs Dermatology. I’m gonna enjoy watching this one. In Particular I can’t Wait to see the managers get their collective tickets punched. Karma baby, karma.